Article (Scientific journals)
Ten Quick Tips for Biomarker Discovery and Validation Analyses Using Machine Learning
Diaz-Uriarte, R.; Gómez de Lope, Elisa; Giugno, R. et al.
2022In PLoS Computational Biology, 18 (8), p. 1010357
Peer Reviewed verified by ORBi
 

Files


Full Text
journal.pcbi.1010357.pdf
Publisher postprint (940.17 kB)
Download

The original publication is available at: https://doi.org/10.1371/journal.pcbi.1010357


All documents in ORBilu are protected by a user license.

Send to



Details



Keywords :
biomarkers; machine learning; stratification; prediction; diagnosis; prognosis; data science; decision medicine; decision support
Abstract :
[en] High-throughput experimental methods for biosample profiling and growing collections of clinical and health record data provide ample opportunities for biomarker discovery and medical decision support. However, many of the new data types, including single-cell omics and high-resolution cellular imaging data, also pose particular challenges for data analysis. A high dimensionality of the data in relation to small numbers of available samples, influences of additive and multiplicative noise, large numbers of uninformative or redundant data features, outliers, confounding factors and imbalanced sample group numbers are all common characteristics of current biomedical data collections. While first successes have been achieved in developing clinical decision support tools using multifactorial omics data, there is still an unmet need and great potential for earlier, more accurate and robust diagnostic and prognostic tools for many complex diseases. Here, we provide a set of broadly applicable tips to address some of the most common pitfalls and limitations for biomarker signature development, including supervised and unsupervised machine learning, feature selection and hypothesis testing approaches. In contrast to previous guidelines discussing detailed aspects of quality control, statistics or study reporting, we give a broader overview of the typical challenges and sort the quick tips to address them chronologically by the study phase (starting with study design, then covering consecutive phases of biomarker signature discovery and validation, see also the overview in Fig. 1). While these tips are not comprehensive, they are chosen to cover what we consider as the most frequent, significant, and practically relevant issues and risks in biomarker development. By pointing the reader to further relevant literature on the covered aspects of biomarker discovery and validation, we hope to provide an initial guideline and entry point into the more detailed technical and application-specific aspects of this field.
Research center :
- Luxembourg Centre for Systems Biomedicine (LCSB): Biomedical Data Science (Glaab Group)
Disciplines :
Human health sciences: Multidisciplinary, general & others
Life sciences: Multidisciplinary, general & others
Biotechnology
Author, co-author :
Diaz-Uriarte, R.
Gómez de Lope, Elisa  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science
Giugno, R.
Fröhlich, H.
Nazarov, Petr ;  University of Luxembourg
Nepomuceno-Chamorro, I. A.
Rauschenberger, Armin ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science
Glaab, Enrico  ;  University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > Biomedical Data Science
External co-authors :
yes
Language :
English
Title :
Ten Quick Tips for Biomarker Discovery and Validation Analyses Using Machine Learning
Publication date :
2022
Journal title :
PLoS Computational Biology
ISSN :
1553-7358
Publisher :
Public Library of Science, San Francisco, United States - California
Volume :
18
Issue :
8
Pages :
e1010357
Peer reviewed :
Peer Reviewed verified by ORBi
Focus Area :
Systems Biomedicine
European Projects :
H2020 - 874825 - PERMIT - PERsonalised MedicIne Trials
FnR Project :
FNR14599012 - Validating Digital Biomarkers For Better Personalized Treatment Of Parkinson'S Disease, 2020 (01/05/2021-30/04/2024) - Enrico Glaab
Name of the research project :
FNR14599012 > Enrico Glaab > DIGIPD > Validating Digital Biomarkers For Better Personalized Treatment Of Parkinson’S Disease > 01/05/2021 > 30/04/2024 > 2020
Funders :
FNR - Fonds National de la Recherche [LU]
European Union - Horizon 2020
CE - Commission Européenne [BE]
Available on ORBilu :
since 26 July 2022

Statistics


Number of views
168 (27 by Unilu)
Number of downloads
28 (2 by Unilu)

Scopus citations®
 
10
Scopus citations®
without self-citations
9
OpenCitations
 
0

Bibliography


Similar publications



Contact ORBilu